Suture

Global $11+ Billion Orthopedic Soft Tissue Repair (Knee, Shoulder, Hip, Small Joints) Market Insights and Forecasts, 2020-2023 & 2024-2030 - ResearchAndMarkets.com

Retrieved on: 
星期一, 五月 20, 2024
General Health, Health, Nursing, Incidence, Prevalence, Application, USD, Human, Osteoarthritis, Ageing, Research, Tendon, Growth, Suture, Hip, Ligament, Knee, Tissue paper

The "Global Orthopedic Soft Tissue Repair Market (2024 Edition): Analysis By Injury Location (Knee, Shoulder, Hip, Small Joints), By Application, By Region, By Country: Market Insights and Forecast (2020-2030)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Orthopedic Soft Tissue Repair Market (2024 Edition): Analysis By Injury Location (Knee, Shoulder, Hip, Small Joints), By Application, By Region, By Country: Market Insights and Forecast (2020-2030)" report has been added to ResearchAndMarkets.com's offering.
  • The Global Orthopedic Soft Tissue Repair Market showcased growth at a CAGR of 6.63 % during 2020-2023.
  • Global Orthopedic Soft Tissue Repair Market: Historic and Forecast
    Global Prevalence of Osteoarthritis By Type, 2019
    Global Incidence of Transport Injuries, 2019
    Top 10 Sports Injuries By Number Of Injuries, 2022 , U.S.
  • Global Orthopedic Soft Tissue Repair Market: Dashboard
    Global Orthopedic Soft Tissue Repair Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
    Global Orthopedic Soft Tissue Repair Market: Market Value Assessment
    Global Orthopedic Soft Tissue Repair Market Segmentation: By Injury Location
    Global Orthopedic Soft Tissue Repair Market, By Injury Location Overview
    Global Orthopedic Soft Tissue Repair Market Attractiveness Index, By Injury Location
    Global Orthopedic Soft Tissue Repair Market Size, By Knee, By Value, 2020H-2030F (USD Million & CAGR)
    Global Orthopedic Soft Tissue Repair Market Size, By Shoulder, By Value, 2020H-2030F (USD Million & CAGR)
    Global Orthopedic Soft Tissue Repair Market Size, By Hip, By Value, 2020H-2030F (USD Million & CAGR)
    Global Orthopedic Soft Tissue Repair Market Size, By Small Joints, By Value, 2020H-2030F (USD Million & CAGR)
    Global Orthopedic Soft Tissue Repair Market Segmentation: By Application
    Global Orthopedic Soft Tissue Repair Market, By Application Overview
    Global Orthopedic Soft Tissue Repair Market Attractiveness Index, By Application
    Global Orthopedic Soft Tissue Repair Market Size, By Gluteal Tendon Repair, By Value, 2020H-2030F (USD Million & CAGR)
    Global Orthopedic Soft Tissue Repair Market Size, By Cruciate Ligaments Repair, By Value, 2020H-2030F (USD Million & CAGR)
    Global Orthopedic Soft Tissue Repair Market Size, By Biceps Tenodesis, By Value, 2020H-2030F (USD Million & CAGR)
    Global Orthopedic Soft Tissue Repair Market Size, By Rotator Cuff Repair, By Value, 2020H-2030F (USD Million & CAGR)
    Global Orthopedic Soft Tissue Repair Market Size, By Achilles Tendinosis Repair, By Value, 2020H-2030F (USD Million & CAGR)
    Global Orthopedic Soft Tissue Repair Market Size, By Hip Arthroscopy, By Value, 2020H-2030F (USD Million & CAGR)
    Global Orthopedic Soft Tissue Repair Market Size, By Other Applications, By Value, 2020H-2030F (USD Million & CAGR)

World's Most Influential People in Ophthalmology

Retrieved on: 
星期四, 五月 9, 2024
Education, FDA, Bascom Palmer Eye Institute, Genetics, Teaching, Surgeon, Paratriathlon, Neuro-ophthalmology, Leach, Strabismus, Cataract, Knowledge, Bascom H. Palmer, Gedde, Eye, DRS, Retina, Vision science, Quality of life, Publication, Research, Bevacizumab, Artificial intelligence, Suture, Health, M.A, Choroideremia, Medeiros, Vance DeGeneres, University, Retinitis pigmentosa, Epidemiology, American Journal, Power, Patient, Physician, Uveitis, Glaucoma, Nursing

MIAMI, May 9, 2024 /PRNewswire/ -- Fifteen Bascom Palmer Eye Institute physicians were selected for the 2024 Power List, a prestigious selection of the world's 100 most influential people shaping the future of eye care, as published by The Ophthalmologist magazine. Drs. Eduardo C. Alfonso, Kendall Donaldson, Hilda Capó, Janet Davis, Harry Flynn, Anat Galor, Steven Gedde, Ranya Habash, Carol Karp, Jaclyn Kovach, Byron Lam, Felipe Medeiros, Richard Parrish, Philip Rosenfeld, and Sonia Yoo were named to the 2024 Power List. Bascom Palmer Eye Institute is the Department of Ophthalmology for the University of Miami Miller School of Medicine and UHealth – University of Miami Health System.

Key Points: 
  • Bascom Palmer Eye Institute is the Department of Ophthalmology for the University of Miami Miller School of Medicine and UHealth – University of Miami Health System.
  • From cutting-edge treatments to groundbreaking research, these doctors are pushing boundaries and setting new standards in ophthalmology."
  • Alfonso, the holder of the Kathleen and Stanley J. Glaser Chair in Ophthalmology, was also named to the Ophthalmologist Power Lists 2014, 2016, 2018, 2022, and 2023.
  • Holder of the John T. Flynn Chair in Ophthalmology, Hilda Capó, M.D., specializes in pediatric ophthalmology and adult strabismus.

Medical Adhesives & Sealants World Market Report 2024: Remineralizing Agents Being Used to Restore Resin-Based Dental Materials - ResearchAndMarkets.com

Retrieved on: 
星期一, 四月 22, 2024
Medical Supplies, Health, Internal, Acrylic, Catheter, Polyurethane, Instrument, Metal, Dental, Fibrin, Cosmetics, Skin, Dentistry, USB On-The-Go, Medical device, Polymer, Suture, Plastic surgery, Adhesive, Surgical instrument, Equipment

The "Medical Adhesives & Sealants World Market Report" has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Medical Adhesives & Sealants World Market Report" has been added to ResearchAndMarkets.com's offering.
  • There are several applications for adhesives and sealants the medical sector, including in the areas of dentistry & cosmetics, internal & external surgery and medical devices & equipment.
  • Among these, acrylic, silicone, polyurethane, polyethylene glycol and cyanoacrylate are most widely used materials to make synthetic/semi-synthetic adhesives & sealants.
  • This world market compendium analyzes the market for Medical Adhesives & Sealants at a high level by resin type/sub-type, application, end-use sector and geographic region.

Vivasure Medical Announces First Large Hole Venous Patient Treated with PerQseal Elite Vascular Closure System

Retrieved on: 
星期一, 四月 15, 2024
Biotechnology, Surgery, Medical Devices, Health, Cardiology, Collagen, Interventional cardiology, TMVR, Safety, Patient, Medicine, Suture, Elite, Medical imaging

Vivasure Medical ®, a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced it has treated the first large bore venous patient with the PerQseal® Elite vascular closure system, a sutureless and fully bioresorbable large-bore vessel closure device.

Key Points: 
  • Vivasure Medical ®, a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced it has treated the first large bore venous patient with the PerQseal® Elite vascular closure system, a sutureless and fully bioresorbable large-bore vessel closure device.
  • Leveraging Vivasure Medical’s PerQseal technology, the PerQseal Elite vascular closure system is designed exclusively for sutureless and fully absorbable large-bore venous vessel closure following percutaneous cardiovascular procedures, such as transcatheter mitral valve repair or replacement (TMVR), transcatheter tricuspid valve repair or replacement (TTVR) and leadless pacemaker implants.
  • “Current venous closure methods are not indicated for large hole venous access applications like Transcatheter Edge-to-Edge repair (TEER), TMVR and TTVR.
  • “We’re encouraged by the early progress we’ve seen in clinical studies of the Elite vascular closure system to address this unmet need.

Neuronoff Announces Safety and Functionality Success in First-in-Human Trial of Injectrode for Minimally Invasive Chronic Pain Relief (LIFE study)

Retrieved on: 
星期二, 四月 23, 2024
Proprioception, Safety, Skin, Analgesic, Principal investigator, Anatomy, Palpation, Patient, Suture, Health, Clinical trial, Chronic pain, Medical device

The company has successfully completed the first-in-human clinical trial evaluating the safety and effectiveness of its flagship product, the Injectrode, designed to treat chronic pain.

Key Points: 
  • The company has successfully completed the first-in-human clinical trial evaluating the safety and effectiveness of its flagship product, the Injectrode, designed to treat chronic pain.
  • Details of the Lumbar Injectrode Feasibility Evaluation, or LIFE study for short, can be found with the NCT06206356 trial identifier.
  • The study, designed primarily as a safety trial with a secondary effectiveness measure, met all goals while providing valuable learnings for future studies.
  • Remarkably, the entire procedure takes just 5-10 minutes, making it highly efficient and accessible for patients seeking relief from chronic pain.

TELA Bio Announces U.S. Commercial Launch of LIQUIFIX™ – the Only FDA-Approved Liquid Adhesive for Internal Use in Hernia Surgery

Retrieved on: 
星期四, 三月 21, 2024
Vein, Consultant, Risk, Anatomy, Surgical mesh, Trauma, Chronic pain, Artery, Surgeon, AMS, FDA, Inguinal hernia, Suture

(NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced the U.S. launch of LIQUIFIX FIX8™ Laparoscopic and LIQUIFIX Precision™ Open Hernia Mesh Fixation Devices.

Key Points: 
  • (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced the U.S. launch of LIQUIFIX FIX8™ Laparoscopic and LIQUIFIX Precision™ Open Hernia Mesh Fixation Devices.
  • LIQUIFIX FIX8 is indicated for minimally invasive femoral and inguinal hernia repairs; and LIQUIFIX Precision is indicated for open femoral and inguinal hernia repairs.
  • The LIQUIFIX devices are the only FDA-approved devices that affix mesh and approximate peritoneal tissue with liquid anchors.
  • LIQUIFIX hernia mesh fixation devices eliminate the need for penetrating mechanical tacks, sutures, or staples by delivering a liquid adhesive that allows for precise and controlled mesh fixation.

Medical Plastics Market Analysis Reveals Expanding Applications and Technological Advances Through 2028 - ResearchAndMarkets.com

Retrieved on: 
星期一, 二月 12, 2024
Chemicals, Plastics, Health, Manufacturing, Medical Supplies, Instrument, World Games, Suction, COVID-19, Syringe, Polyethylene, Medicine, Patient, Suture, Medical device

In 2022, the global market for medical plastics was dominated by the North American region.

Key Points: 
  • In 2022, the global market for medical plastics was dominated by the North American region.
  • North America holds a 42.3% share of the global medical plastics market.
  • The base year considered for analysis is 2022, and the market estimates and forecasts are given from 2023 to 2028.
  • The scope for the medical plastics market is segmented into application and resin type.

Ascend to showcase health care innovations at MD&M West

Retrieved on: 
星期五, 二月 2, 2024
Suture, Booth, MD, Ascend, Caregiver, Safety, Medicine, Instrument, Splints, Catheter, Skin, Metal, Patient, Medtech

HOUSTON, Feb. 2, 2024 /PRNewswire/ -- Ascend Performance Materials will introduce new products from its expanding health care brands, Acteev MED™ and HiDura® MED, at the Medical Design & Manufacturing West show next week in Anaheim, California. It is the first time the company has exhibited its longstanding medical business at the show.

Key Points: 
  • It is the first time the company has exhibited its longstanding medical business at the show.
  • Our materials feel soothing without sacrificing performance
    Ascend's medical business and technology experts will showcase novel and traditional solutions for medical durables, packaging, surgical instruments, wound care applications and more.
  • A novel nylon is malleable yet retains its shape, offering an imaging-ready replacement for flexible metals in applications such as splints.
  • The Acteev MED and HiDura MED teams will exhibit at Booth 673 across from the MedTech Theater at MD&M West from February 6-8, 2024.

ACCLARO MEDICAL TO SHOWCASE INNOVATIVE LASER-CORING APPLICATION OF ITS ULTRACLEAR LASER AT IMCAS 2024, THE PREMIER GLOBAL SCIENTIFIC AESTHETICS CONGRESS

Retrieved on: 
星期五, 一月 26, 2024
Scar, Laser, Patient, JD, Sleep, International business development, DRS, Result, Skin, Safety, Suture, Treatment, Ageing, Use, Physician, Medical device

During his session, Dr. Goldberg will delve into UltraClear Laser's unique tunable pulsing technology to precisely target multiple skin depths – from superficial to deep penetration -- while minimizing collateral thermal damage. Showcasing impressive treatment photos, he will highlight the visible aesthetic results achieved with UltraClear Laser to correct numerous skin conditions, as will Drs. Catherine DiGiorgio, Michael Gold and Shanthala Shivananjappa during their respective podium talks.

Key Points: 
  • SMITHFIELD, R.I., Jan. 26, 2024 /PRNewswire/ -- Acclaro Medical will present new clinical results and best practices for performing UltraClear Laser-Coring™ – a "first-of-its-kind" laser-enabled tissue coring technique using its novel 2910 nm cold fiber laser platform UltraClear® at the IMCAS 2024 aesthetics global congress, which launches on 1-3 February in Paris, France.
  • Showcasing impressive treatment photos, he will highlight the visible aesthetic results achieved with UltraClear Laser to correct numerous skin conditions, as will Drs.
  • UltraClear Laser-Coring provides a breakthrough in collagen remodeling by combining fractional tissue coring and laser resurfacing without scalpels or sutures in a 30-minute treatment.
  • UltraClear Laser-Coring can be combined with multiple UltraClear resurfacing modes to address various cosmetic concerns in a single treatment.

ACCLARO MEDICAL TO SHOWCASE INNOVATIVE LASER-CORING APPLICATION OF ITS ULTRACLEAR LASER AT IMCAS 2024, THE PREMIER GLOBAL SCIENTIFIC AESTHETICS CONGRESS

Retrieved on: 
星期五, 一月 26, 2024
Scar, Laser, Patient, JD, Sleep, International business development, DRS, Result, Skin, Safety, Suture, Treatment, Ageing, Use, Physician, Medical device

During his session, Dr. Goldberg will delve into UltraClear Laser's unique tunable pulsing technology to precisely target multiple skin depths – from superficial to deep penetration -- while minimizing collateral thermal damage. Showcasing impressive treatment photos, he will highlight the visible aesthetic results achieved with UltraClear Laser to correct numerous skin conditions, as will Drs. Catherine DiGiorgio, Michael Gold and Shanthala Shivananjappa during their respective podium talks.

Key Points: 
  • SMITHFIELD, R.I., Jan. 26, 2024 /PRNewswire/ -- Acclaro Medical will present new clinical results and best practices for performing UltraClear Laser-Coring™ – a "first-of-its-kind" laser-enabled tissue coring technique using its novel 2910 nm cold fiber laser platform UltraClear® at the IMCAS 2024 aesthetics global congress, which launches on 1-3 February in Paris, France.
  • Showcasing impressive treatment photos, he will highlight the visible aesthetic results achieved with UltraClear Laser to correct numerous skin conditions, as will Drs.
  • UltraClear Laser-Coring provides a breakthrough in collagen remodeling by combining fractional tissue coring and laser resurfacing without scalpels or sutures in a 30-minute treatment.
  • UltraClear Laser-Coring can be combined with multiple UltraClear resurfacing modes to address various cosmetic concerns in a single treatment.